DENTSPLY SIRONA (NASDAQ:XRAY) Updates Q2 2025 Earnings Guidance

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) issued an update on its second quarter 2025 earnings guidance on Monday morning. The company provided EPS guidance of 0.500-0.520 for the period, compared to the consensus EPS estimate of 0.497. The company issued revenue guidance of $935.0 million-$935.0 million, compared to the consensus revenue estimate of $931.3 million.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ XRAY traded down $0.34 during midday trading on Thursday, reaching $16.52. The company had a trading volume of 795,675 shares, compared to its average volume of 2,831,239. The business's 50-day simple moving average is $16.05 and its 200 day simple moving average is $16.24. The stock has a market cap of $3.29 billion, a P/E ratio of -3.64, a P/E/G ratio of 1.17 and a beta of 0.94. DENTSPLY SIRONA has a 1 year low of $12.16 and a 1 year high of $27.95. The company has a current ratio of 1.10, a quick ratio of 0.76 and a debt-to-equity ratio of 0.79.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, beating the consensus estimate of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. The business had revenue of $879.00 million during the quarter, compared to analysts' expectations of $854.75 million. During the same period in the previous year, the business posted $0.42 EPS. The business's quarterly revenue was down 7.8% compared to the same quarter last year. On average, analysts forecast that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 11th. Shareholders of record on Friday, June 27th were paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 3.88%. The ex-dividend date of this dividend was Friday, June 27th. DENTSPLY SIRONA's payout ratio is -14.10%.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research note on Monday. UBS Group decreased their price objective on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a research note on Friday, May 9th. Piper Sandler decreased their target price on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research note on Wednesday, April 30th. Morgan Stanley cut shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price for the company. in a research note on Tuesday, April 15th. Finally, Barrington Research reiterated an "outperform" rating and issued a $21.00 target price on shares of DENTSPLY SIRONA in a research note on Tuesday. Ten analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $19.60.

Institutional Investors Weigh In On DENTSPLY SIRONA

Large investors have recently modified their holdings of the business. Goldman Sachs Group Inc. grew its holdings in shares of DENTSPLY SIRONA by 827.3% in the first quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier's stock valued at $36,378,000 after purchasing an additional 2,172,343 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of DENTSPLY SIRONA by 7.5% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 593,021 shares of the medical instruments supplier's stock worth $8,860,000 after purchasing an additional 41,579 shares in the last quarter. Focus Partners Wealth lifted its position in shares of DENTSPLY SIRONA by 59.1% during the first quarter. Focus Partners Wealth now owns 25,181 shares of the medical instruments supplier's stock worth $376,000 after purchasing an additional 9,355 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in shares of DENTSPLY SIRONA during the first quarter worth approximately $26,000. Finally, Empowered Funds LLC increased its stake in shares of DENTSPLY SIRONA by 8.8% during the first quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier's stock worth $244,000 after buying an additional 1,320 shares during the period. Hedge funds and other institutional investors own 95.70% of the company's stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.